SCHEMBL8559868

SCHEMBL8559868

CCC(C)Nc1ccc(C)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.82
CYP3A4 P08684 3/20 0.82
ALOX15 P16050 2/20 0.82
TSHR P16473 2/20 0.82
HIF1A Q16665 2/20 0.82
HSD17B10 Q99714 2/20 0.82
L3MBTL1 Q9Y468 2/20 0.82
SMN1; SMN2 Q16637 2/20 0.82
TDP1 Q9NUW8 2/20 0.82
TP53 P04637 1/20 0.82
HSP90AA1 P07900 1/20 0.82
THRB P10828 1/20 0.82
CASP1 P29466 1/20 0.82
MAPT P10636 2/20 0.44
CA12 O43570 2/20 0.44
CA1 P00915 1/20 0.44
MMP8 P22894 1/20 0.44
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL49805 0.91 ALDH1A1 (1.00) ALDH1A1CYP3A4ALOX15TSHRHIF1A
Glycolic Acid SCHEMBL8595822 0.86 ALDH1A1 (0.60) ALDH1A1CYP3A4ALOX15TSHRHIF1A
SCHEMBL9874686 0.84 ALDH1A1 (0.86) ALDH1A1CYP3A4ALOX15TSHRHIF1A
SCHEMBL11482583 0.84 ALDH1A1 (0.86) ALDH1A1CYP3A4ALOX15TSHRHIF1A
SCHEMBL9572276 0.84 ALDH1A1 (0.86) ALDH1A1CYP3A4ALOX15TSHRHIF1A
SCHEMBL1844486 0.84 ALDH1A1 (0.86) ALDH1A1CYP3A4ALOX15TSHRHIF1A
SCHEMBL11466441 0.82 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHIF1A
Methane SCHEMBL21294035 0.82 ALDH1A1 (0.82) ALDH1A1CYP3A4ALOX15TSHRHIF1A
SCHEMBL24564966 0.80 ALDH1A1 (0.63) ALDH1A1CYP3A4ALOX15TSHRHIF1A
SCHEMBL21256944 0.80 ALDH1A1 (0.52) ALDH1A1CYP3A4ALOX15TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220112242-A1 SOMATOSTATIN RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USING THE SAME CDRD VENTURES INC. (CA) 2022-04-14 US disclosed
US-9455408-B2 Layered structure, polymer, electroluminescent device, and photoelectric conversion device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-09-27 US disclosed
CN-103974991-B Expansion joint comprising a hybrid polyurea-polyurethane end composition 建筑研究和技术有限公司 2016-08-31 CN disclosed
US-9276237-B2 Method for producing organic EL element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-01 US disclosed
US-9159922-B2 Method for manufacturing organic electroluminescent element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-13 US disclosed
US-9006008-B2 Method for manufacturing organic electroluminescent element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-04-14 US disclosed
US-8963422-B2 Method for manufacturing organic light-emitting device and organic light-emitting device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-02-24 US disclosed
US-8927978-B2 Organic EL element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-01-06 US disclosed
CN-103974991-A Expansion joint comprising a hybrid polyurea-polyurethane end composition CONSTR RES & TECH GMBH 2014-08-06 CN disclosed
US-20130181205-A1 ORGANIC EL ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-07-18 US disclosed
US-20130183782-A1 METHOD FOR PRODUCING ORGANIC EL ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-07-18 US disclosed
US-20130134410-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR MANUFACTURING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-05-30 US disclosed
EP-2597696-A1 ORGANIC EL ELEMENT Sumitomo Chemical Company Limited (JP) 2013-05-29 EP disclosed
EP-2597932-A1 MANUFACTURING METHOD FOR ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC LIGHT-EMITTING DEVICE Sumitomo Chemical Company, Limited (JP) 2013-05-29 EP disclosed
EP-2597933-A1 MANUFACTURING METHOD FOR ORGANIC ELECTROLUMINESCENCE ELEMENT Sumitomo Chemical Company, Limited (JP) 2013-05-29 EP disclosed
US-20130122625-A1 METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT SUMITOMO CHEMICAL CO., LTD. (JP) 2013-05-16 US disclosed
US-20130112966-A1 METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-05-09 US disclosed
US-5712414-A Hydroxycarboxylic acid anilides HOECHST AKTIENGESELLSCHAFT (DE) 1998-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220112242-A1 SOMATOSTATIN RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USING THE SAME GPR119, SSTR5, SSTR2 ALDH1A1 4110/4885CYP3A4 3742/4885ALOX15 2333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.